Pancreatic Cancer Research

ResearcherPeking University Third HospitalNo recent work listed

Dianrong Xiu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1475-6629; OpenAlex author ID A5101700937. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: none · 2021: 1 paper

Papers 4

  1. KLHDC7B-DT aggravates pancreatic ductal adenocarcinoma development via inducing cross-talk between cancer cells and macrophages. Last author DOI 10.1042/cs20201259↗
  2. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer. Co-author DOI 10.1007/s11306-019-1550-1↗
  3. Serum Derived Exosomes From Pancreatic Cancer Patients Promoted Metastasis: An iTRAQ-Based Proteomic Analysis. Last author DOI 10.2147/ott.s229494↗
  4. High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. First author DOI 10.2147/ott.s111382↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lingfu Zhang · 3 shared papers, 2016–2019 · strength 0.28
  2. Chunhui Yuan · 2 shared papers, 2019 · strength 0.23
  3. Lianyuan Tao · 2 shared papers, 2019 · strength 0.23
  4. Muxing Li · 1 shared paper, 2021 · strength 0.14
  5. Chunhui Yuan · 1 shared paper, 2021 · strength 0.14
  6. Lei Li · 1 shared paper, 2021 · strength 0.14
  7. Bin Jiang · 1 shared paper, 2021 · strength 0.14
  8. Li Zhang · 1 shared paper, 2021 · strength 0.14
  9. Puxian Tang · 1 shared paper, 2019 · strength 0.12
  10. Lijun Zhong · 1 shared paper, 2019 · strength 0.10
  11. Deyu Li · 1 shared paper, 2019 · strength 0.10
  12. Juntuo Zhou · 1 shared paper, 2019 · strength 0.10
  13. Hongquan Zhang · 1 shared paper, 2016 · strength 0.06
  14. Jun Zhan · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.